Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology

Michael B. Kays, Christopher R. Lisek, Gerald Denys

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Broth microdilution MICs were determined for 14 antimicrobial agents against 296 clinical, non-duplicate isolates of Streptococcus pneumoniae collected at Methodist Hospital (Indianapolis, Indiana, USA) from January 2001 to December 2003. Isolates were categorized as susceptible, intermediate, or resistant using Clinical and Laboratory Standards Institute breakpoints. Time-kill studies were performed to evaluate the bactericidal activity of telithromycin at 1, 2, 4, and 8× MIC against 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant (7 M-phenotype, 3 MLSB-phenotype) strains. Bactericidal activity was defined as a ≥3-log10 reduction in CFU/mL. The prevalence of resistance was highest for the macrolides (32%), followed by penicillin (16.2%), clindamycin (10.8%), amoxicillin ± clavulanate (4.4%), levofloxacin (3.0%), gatifloxacin and moxifloxacin (2.4%), ceftriaxone and cefotaxime (2.0%), and gemifloxacin (1.4%). None of the isolates tested were resistant to telithromycin. At 24 h, telithromycin was bactericidal for 0/10, 2/10, 7/10, and 7/10 isolates at 1× MIC, 2× MIC, 4× MIC, and 8× MIC, respectively. At 4-8× MIC, telithromycin was bactericidal for 7/7 M-phenotype isolates and 0/3 MLSB-phenotype isolates. For the MLSB-phenotype isolates, colony counts were decreased by 1.3-2.1 log10 colony-forming units/mL after 24 h at 8× MIC. Overall, telithromycin was highly active against 296 isolates of S. pneumoniae from our institution and demonstrated bactericidal activity at clinically achievable concentrations for 7 of 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant S. pneumoniae. However, telithromycin was bacteriostatic for the MLSB-phenotype isolates.

Original languageEnglish (US)
Pages (from-to)289-294
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Volume29
Issue number3
DOIs
StatePublished - Mar 1 2007

Fingerprint

Levofloxacin
Macrolides
Streptococcus pneumoniae
Penicillins
Phenotype
Clavulanic Acid
Cefotaxime
Clindamycin
Ceftriaxone
Amoxicillin
Anti-Infective Agents
telithromycin
In Vitro Techniques
Stem Cells

Keywords

  • Bactericidal
  • Resistance
  • Streptococcus pneumoniae
  • Telithromycin
  • Time-kill

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

@article{aaeacbc2cc924d4b938e7b52ff94ae47,
title = "Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology",
abstract = "Broth microdilution MICs were determined for 14 antimicrobial agents against 296 clinical, non-duplicate isolates of Streptococcus pneumoniae collected at Methodist Hospital (Indianapolis, Indiana, USA) from January 2001 to December 2003. Isolates were categorized as susceptible, intermediate, or resistant using Clinical and Laboratory Standards Institute breakpoints. Time-kill studies were performed to evaluate the bactericidal activity of telithromycin at 1, 2, 4, and 8× MIC against 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant (7 M-phenotype, 3 MLSB-phenotype) strains. Bactericidal activity was defined as a ≥3-log10 reduction in CFU/mL. The prevalence of resistance was highest for the macrolides (32{\%}), followed by penicillin (16.2{\%}), clindamycin (10.8{\%}), amoxicillin ± clavulanate (4.4{\%}), levofloxacin (3.0{\%}), gatifloxacin and moxifloxacin (2.4{\%}), ceftriaxone and cefotaxime (2.0{\%}), and gemifloxacin (1.4{\%}). None of the isolates tested were resistant to telithromycin. At 24 h, telithromycin was bactericidal for 0/10, 2/10, 7/10, and 7/10 isolates at 1× MIC, 2× MIC, 4× MIC, and 8× MIC, respectively. At 4-8× MIC, telithromycin was bactericidal for 7/7 M-phenotype isolates and 0/3 MLSB-phenotype isolates. For the MLSB-phenotype isolates, colony counts were decreased by 1.3-2.1 log10 colony-forming units/mL after 24 h at 8× MIC. Overall, telithromycin was highly active against 296 isolates of S. pneumoniae from our institution and demonstrated bactericidal activity at clinically achievable concentrations for 7 of 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant S. pneumoniae. However, telithromycin was bacteriostatic for the MLSB-phenotype isolates.",
keywords = "Bactericidal, Resistance, Streptococcus pneumoniae, Telithromycin, Time-kill",
author = "Kays, {Michael B.} and Lisek, {Christopher R.} and Gerald Denys",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.ijantimicag.2006.09.024",
language = "English (US)",
volume = "29",
pages = "289--294",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology

AU - Kays, Michael B.

AU - Lisek, Christopher R.

AU - Denys, Gerald

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Broth microdilution MICs were determined for 14 antimicrobial agents against 296 clinical, non-duplicate isolates of Streptococcus pneumoniae collected at Methodist Hospital (Indianapolis, Indiana, USA) from January 2001 to December 2003. Isolates were categorized as susceptible, intermediate, or resistant using Clinical and Laboratory Standards Institute breakpoints. Time-kill studies were performed to evaluate the bactericidal activity of telithromycin at 1, 2, 4, and 8× MIC against 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant (7 M-phenotype, 3 MLSB-phenotype) strains. Bactericidal activity was defined as a ≥3-log10 reduction in CFU/mL. The prevalence of resistance was highest for the macrolides (32%), followed by penicillin (16.2%), clindamycin (10.8%), amoxicillin ± clavulanate (4.4%), levofloxacin (3.0%), gatifloxacin and moxifloxacin (2.4%), ceftriaxone and cefotaxime (2.0%), and gemifloxacin (1.4%). None of the isolates tested were resistant to telithromycin. At 24 h, telithromycin was bactericidal for 0/10, 2/10, 7/10, and 7/10 isolates at 1× MIC, 2× MIC, 4× MIC, and 8× MIC, respectively. At 4-8× MIC, telithromycin was bactericidal for 7/7 M-phenotype isolates and 0/3 MLSB-phenotype isolates. For the MLSB-phenotype isolates, colony counts were decreased by 1.3-2.1 log10 colony-forming units/mL after 24 h at 8× MIC. Overall, telithromycin was highly active against 296 isolates of S. pneumoniae from our institution and demonstrated bactericidal activity at clinically achievable concentrations for 7 of 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant S. pneumoniae. However, telithromycin was bacteriostatic for the MLSB-phenotype isolates.

AB - Broth microdilution MICs were determined for 14 antimicrobial agents against 296 clinical, non-duplicate isolates of Streptococcus pneumoniae collected at Methodist Hospital (Indianapolis, Indiana, USA) from January 2001 to December 2003. Isolates were categorized as susceptible, intermediate, or resistant using Clinical and Laboratory Standards Institute breakpoints. Time-kill studies were performed to evaluate the bactericidal activity of telithromycin at 1, 2, 4, and 8× MIC against 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant (7 M-phenotype, 3 MLSB-phenotype) strains. Bactericidal activity was defined as a ≥3-log10 reduction in CFU/mL. The prevalence of resistance was highest for the macrolides (32%), followed by penicillin (16.2%), clindamycin (10.8%), amoxicillin ± clavulanate (4.4%), levofloxacin (3.0%), gatifloxacin and moxifloxacin (2.4%), ceftriaxone and cefotaxime (2.0%), and gemifloxacin (1.4%). None of the isolates tested were resistant to telithromycin. At 24 h, telithromycin was bactericidal for 0/10, 2/10, 7/10, and 7/10 isolates at 1× MIC, 2× MIC, 4× MIC, and 8× MIC, respectively. At 4-8× MIC, telithromycin was bactericidal for 7/7 M-phenotype isolates and 0/3 MLSB-phenotype isolates. For the MLSB-phenotype isolates, colony counts were decreased by 1.3-2.1 log10 colony-forming units/mL after 24 h at 8× MIC. Overall, telithromycin was highly active against 296 isolates of S. pneumoniae from our institution and demonstrated bactericidal activity at clinically achievable concentrations for 7 of 10 penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant S. pneumoniae. However, telithromycin was bacteriostatic for the MLSB-phenotype isolates.

KW - Bactericidal

KW - Resistance

KW - Streptococcus pneumoniae

KW - Telithromycin

KW - Time-kill

UR - http://www.scopus.com/inward/record.url?scp=33846972314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846972314&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2006.09.024

DO - 10.1016/j.ijantimicag.2006.09.024

M3 - Article

VL - 29

SP - 289

EP - 294

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 3

ER -